Find the latest SpringWorks Therapeutics, Inc. (SWTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

2 days ago · BofA analyst Alec Stranahan raised the firm’s price target on SpringWorks Therapeutics to $65 from $55 and keeps a Buy rating on the shares.While the possibility of a potential takeout of ...

Feb 20, 2025 · The Investor Relations website contains information about SpringWorks Therapeutics's business for stockholders, potential investors, and financial analysts.

Jan 3, 2025 · At SpringWorks, we bring tenacity to work every day because patients need answers now. Our late-stage rare oncology programs have the potential to be best-in-class treatments for patients with devastating diseases.

2 days ago · See the latest SpringWorks Therapeutics Inc Ordinary Shares stock price (SWTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Jan 30, 2025 · Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines....

2 days ago · A closeup of a scientist in a lab coat, mixing two liquids for a compound to treat rare diseases. SpringWorks Therapeutics Inc. (NASDAQ:SWTX) SpringWorks Therapeutics Inc. rallied by 34.06 percent ...

23 hours ago · SpringWorks Therapeutics (SWTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Get the latest SpringWorks Therapeutics Inc (SWTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from...